Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Edinger, NJ

Alfred R. Edinger, Toms River, NJ US

Patent application numberDescriptionPublished
20100230555Universal holding device - These three embodiment(s) possess some/all of basic elements/components/characteristics. They disclose either Open-Circle or U-Shape design(s). Universal Holding Device (Adjustable) (FIG. 09-16-2010
20110001022Universal holding device - Universal Holding Device has two embodiments, second one possess most of basic parts. One has an inverted ā€œUā€ Shape and other has ā€œLā€ shape designs.01-06-2011

James Edinger, Belford, NJ US

Patent application numberDescriptionPublished
20100183571TREATMENT OF MULTIPLE SCLEROSIS USING PLACENTAL STEM CELLS - The present invention provides methods of immunomodulation using placental stem cells and placental stem cell populations. The invention also provides methods of producing and selecting placental cells and cell populations on the basis of immunomodulation, and compositions comprising such cells and cell populations.07-22-2010
20100297689PLACENTAL STEM CELL POPULATIONS - The present invention provides placental stem cells and placental stem cell populations, and methods of culturing, proliferating and expanding the same. The invention also provides methods of differentiating the placental stem cells. The invention further provides methods of using the placental stem cells in assays and for transplanting.11-25-2010

Patent applications by James Edinger, Belford, NJ US

James W. Edinger, Belford, NJ US

Patent application numberDescriptionPublished
20080206343Hepatocytes and Chondrocytes from Adherent Placental StemCells; And CD34+ ,CD45- Placental Stem Cell-Enriched Cell Populations - Provided herein are methods and compositions for the production of hepatocytes from placenta stem cells. Further provided herein is the use of such hepatocytes in the treatment of, and intervention in, for example, trauma, inflammation, and degenerative disorders of the liver. Also provided herein are compositions and methods relating to combinations of nanofibrous scaffolds and adherent placental stem cells and methods of using the same in cartilage repair. Finally, provided herein are compositions and methods relating to nonadherent, CD3408-28-2008
20080213228Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations - Provided herein are methods of using adherent placental stem cells and placental stem cell populations, and methods of culturing, proliferating and expanding the same. Also provided herein are methods of differentiating the placental stem cells. Further provided herein are methods of using the placental stem cells to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are provides methods for treating bone defects with stem cells and compositions comprising stem cells.09-04-2008
20080226595TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL STEM CELLS - Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.09-18-2008
20100124569AMNION DERIVED ADHERENT CELLS - Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.05-20-2010
20100291679COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION - The present invention provides improved compositions and methods for the collection of stem cells from an organ, e.g., placenta. The invention provides a stem cell collection composition comprising an apoptosis inhibitor and, optionally, an enzyme such as a protease or mucolytic enzyme, vasodilator, necrosis inhibitor, oxygen-carrying perfluorocarbon, or an organ preserving compound. The invention provides methods of using the stem cell collection composition to collect stem cells and to preserve populations of stem cells.11-18-2010

Patent applications by James W. Edinger, Belford, NJ US

Kathleen Ellen Edinger, Belford, NJ US